Vanessa Malier - Profile and Investment Details

Investor Profile

Vanessa Malier is a Venture Capital, Private Equity Firm, Investor based in Paris, Île-de-France, France with a diverse investment portfolio that includes companies such as AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Ipsen, Asceneuron, IO Biotech, Vico Therapeutics, ARGOBIO, DNA Script, STAT-Dx, Tacalyx, Synendos Therapeutics, Xeltis, ImCheck Therapeutics, Orphazyme, Sensome, Mila, Corlieve Therapeutics, Horama, Minoryx Therapeutics, Meiogenix, Safe OrthopaedicsStep Pharma, Lucine, BliNK Biomedical, Five Arrows, ABM Pharma, Cardiologs, Antag Therapeutics, DeepUll, Asarina Pharma, Nuage Therapeutics, PathoQuest, Medlumics, Alizé Pharma, BioSerenity, Fondation Pour l'Audition, Vivet Therapeutics, Ermium Therapeutics, Pharvaris, Dynacure, DAMAE Medical, Stilla Technologies, OxThera, . Over time, Vanessa Malier has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Vanessa Malier is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Wellness, CRM, Life Science, Engineering, Education, Robotics, Information Technology (IT), Software, Biotechnology, Electronic Health Records (EHR), Health and Hospital Services, Innovation, Neuroscience, Research, Consulting, Health Diagnostics, Medical, Big Data, B2B, Therapeutics, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Vanessa Malier, as their portfolio suggests a familiarity and interest in this area.

Understanding Vanessa Malier’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.